Pralatrexate
In Stock•Starting at $158 for 50 mg•Purity ≥ 98%
| CAS No. | 146464-95-1 |
|---|---|
| MDL No. | MFCD00920897 |
| MF | C23H23N7O5 |
| MW | 477.50 |
| InChI Key | OGSBUKJUDHAQEA-WMCAAGNKSA-N |
Pricing & Availability
| Pack Size | Purity | Price | Availability | Action |
|---|---|---|---|---|
| 50 mg | 98% | $158 | In Stock | |
| 100 mg | 98% | $251 | In Stock | |
| 1 g | 98% | $1037 | In Stock | |
| Custom synthesis and bulk supply options are available upon request. | ||||
Product Information
Pralatrexate is a pteridine derivative of L-glutamic acid, specifically the N-4-[1-(2,4-diaminopteridin-6-yl)pent-4-yn-2-yl]benzoyl form. It is used to treat peripheral T-cell lymphoma, an aggressive non-Hodgkin's lymphoma. It functions as an antineoplastic agent, antimetabolite, and inhibitor of dihydrofolate reductase (EC 1.5.1.3). It is also a N-acyl-L-glutamic acid, a pteridine, and a terminal acetylenic compound.
| CAS No. | 146464-95-1 |
|---|---|
| Product Name | Pralatrexate |
Biological Targets
DHFR
Associated Conditions
multiple myeloma·Cutaneous T-cell lymphoma·mature T-cell and NK-cell non-Hodgkin lymphoma·Sezary's disease·T-cell non-Hodgkin lymphoma·
* The information provided here is compiled from public sources and is for reference only.
